双-(2-甲基萘酰基)甲烷衍生物的合成、硅基潜在酶靶点预测、药代动力学、毒性、抗微生物和抗炎研究

Q4 Pharmacology, Toxicology and Pharmaceutics
Dnyaneshwar T. Nagre, Suraj N. Mali, B. Thorat, S. A. Thorat, A. Chopade, M. Farooqui, B. Agrawal
{"title":"双-(2-甲基萘酰基)甲烷衍生物的合成、硅基潜在酶靶点预测、药代动力学、毒性、抗微生物和抗炎研究","authors":"Dnyaneshwar T. Nagre, Suraj N. Mali, B. Thorat, S. A. Thorat, A. Chopade, M. Farooqui, B. Agrawal","doi":"10.2174/1573408017666210203203735","DOIUrl":null,"url":null,"abstract":"\n\nThe bis(indolyl)methanes (BIMs) scaffold is being reported for wide varieties of pharmacological profiles including anti-bacterial, anti-proliferative, anti-cancer, cytotoxic, insecticidal, analgesic, antioxidant, and anti-inflammatory agents.\n\n\n\nA series of bis(indolyl)methanes have been synthesized using greener and new approach using the reaction of different substituted aldehydes and indole in presence of easily available and biodegradable base such as piperidine in acetic acid at room temperature and characterized with ultraviolet–visible spectrophotometry (UV–Vis or UV/Vis),Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy(NMR),etc. The antibacterial and antifungal activities were also carried out against Staphylococcus aureus (RCMB 000106) and Bacillis subtilis (RCMB 000107), as two Gram positive bacterial strains and Salmonella typhi and Escherichia coli (RCMB 000103), as two Gram negative bacterial strains. Fungal Species such as Candida Albicans, Penicillium chrysogenum, Aspergillus niger were also used for in-vitro antifungal evaluation. All our newly synthesized 14 compounds (4a-4n) were subjected for anti-inflammatory activity in-vitro and compared with known standard drug Aceclofenac. \n\n\n\nOur newly synthesized compounds showed good to moderate antibacterial agents, in-silico ADMET and anti-inflammatory profiles. We hope that our current study would aid future developments of bis(indolyl)methanes as antibacterial and anti-inflammatory agents.\n","PeriodicalId":35405,"journal":{"name":"Current Enzyme Inhibition","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Synthesis, In-Silico Potential Enzymatic target predictions, Pharmacokinetics, Toxicity, Anti-Microbial and Anti-Inflammatory Studies of Bis-(2-methylindolyl) methane Derivatives\",\"authors\":\"Dnyaneshwar T. Nagre, Suraj N. Mali, B. Thorat, S. A. Thorat, A. Chopade, M. Farooqui, B. Agrawal\",\"doi\":\"10.2174/1573408017666210203203735\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nThe bis(indolyl)methanes (BIMs) scaffold is being reported for wide varieties of pharmacological profiles including anti-bacterial, anti-proliferative, anti-cancer, cytotoxic, insecticidal, analgesic, antioxidant, and anti-inflammatory agents.\\n\\n\\n\\nA series of bis(indolyl)methanes have been synthesized using greener and new approach using the reaction of different substituted aldehydes and indole in presence of easily available and biodegradable base such as piperidine in acetic acid at room temperature and characterized with ultraviolet–visible spectrophotometry (UV–Vis or UV/Vis),Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy(NMR),etc. The antibacterial and antifungal activities were also carried out against Staphylococcus aureus (RCMB 000106) and Bacillis subtilis (RCMB 000107), as two Gram positive bacterial strains and Salmonella typhi and Escherichia coli (RCMB 000103), as two Gram negative bacterial strains. Fungal Species such as Candida Albicans, Penicillium chrysogenum, Aspergillus niger were also used for in-vitro antifungal evaluation. All our newly synthesized 14 compounds (4a-4n) were subjected for anti-inflammatory activity in-vitro and compared with known standard drug Aceclofenac. \\n\\n\\n\\nOur newly synthesized compounds showed good to moderate antibacterial agents, in-silico ADMET and anti-inflammatory profiles. We hope that our current study would aid future developments of bis(indolyl)methanes as antibacterial and anti-inflammatory agents.\\n\",\"PeriodicalId\":35405,\"journal\":{\"name\":\"Current Enzyme Inhibition\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-02-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Enzyme Inhibition\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573408017666210203203735\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Enzyme Inhibition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573408017666210203203735","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 9

摘要

据报道,双(吲哚基)甲烷(BIM)支架具有多种药理特征,包括抗菌、抗增殖、抗癌、细胞毒性、杀虫、镇痛、抗氧化和抗炎剂。利用不同取代醛和吲哚在易得且可生物降解的碱(如哌啶)存在下在室温下在乙酸中反应,采用更环保的新方法合成了一系列双(吲哚基)甲烷,并用紫外-可见分光光度法(UV–Vis或UV/Vis)、傅立叶变换红外光谱法(FTIR),核磁共振波谱(NMR)等。对金黄色葡萄球菌(RCMB 000106)和枯草芽孢杆菌(RCMB 0001 07)这两种革兰氏阳性菌株以及伤寒沙门氏菌和大肠杆菌(RCGB 000103)这两个革兰氏阴性菌株也进行了抗菌和抗真菌活性。真菌种类如白色念珠菌、产黄青霉、黑曲霉也用于体外抗真菌评价。我们所有新合成的14个化合物(4a-4n)都在体外进行了抗炎活性测试,并与已知的标准药物Aceclofenac进行了比较。我们新合成的化合物在硅ADMET和抗炎方面表现出良好至中度的抗菌剂。我们希望我们目前的研究将有助于双(吲哚基)甲烷作为抗菌和抗炎剂的未来发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Synthesis, In-Silico Potential Enzymatic target predictions, Pharmacokinetics, Toxicity, Anti-Microbial and Anti-Inflammatory Studies of Bis-(2-methylindolyl) methane Derivatives
The bis(indolyl)methanes (BIMs) scaffold is being reported for wide varieties of pharmacological profiles including anti-bacterial, anti-proliferative, anti-cancer, cytotoxic, insecticidal, analgesic, antioxidant, and anti-inflammatory agents. A series of bis(indolyl)methanes have been synthesized using greener and new approach using the reaction of different substituted aldehydes and indole in presence of easily available and biodegradable base such as piperidine in acetic acid at room temperature and characterized with ultraviolet–visible spectrophotometry (UV–Vis or UV/Vis),Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance spectroscopy(NMR),etc. The antibacterial and antifungal activities were also carried out against Staphylococcus aureus (RCMB 000106) and Bacillis subtilis (RCMB 000107), as two Gram positive bacterial strains and Salmonella typhi and Escherichia coli (RCMB 000103), as two Gram negative bacterial strains. Fungal Species such as Candida Albicans, Penicillium chrysogenum, Aspergillus niger were also used for in-vitro antifungal evaluation. All our newly synthesized 14 compounds (4a-4n) were subjected for anti-inflammatory activity in-vitro and compared with known standard drug Aceclofenac. Our newly synthesized compounds showed good to moderate antibacterial agents, in-silico ADMET and anti-inflammatory profiles. We hope that our current study would aid future developments of bis(indolyl)methanes as antibacterial and anti-inflammatory agents.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Enzyme Inhibition
Current Enzyme Inhibition Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
1.30
自引率
0.00%
发文量
30
期刊介绍: Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信